Antonio Marra

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Venues

NPJ precision oncology

Nature reviews. Clinical oncology

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Istituto Europeo di Oncologia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Europeo di Oncologia

Italy

Medical Doctor :: Medical Oncology

Ospedale San Paolo

Italy

Medical Doctor :: Medical Oncology

Publications

Higinio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, David N Brown, Pier Selenica, Sahar Jalali, Arnaud Da Cruz Paula, Antonio Marra, Edaise M Da Silva, Thais Basili, Laxmi Gusain, Lorraine Colon-Cartagena, Shirin Issa Bhaloo, Hunter Green, Chad Vanderbilt, Steffi Oesterreich, Anne Grabenstetter, M Gabriela Kuba, Dara Ross, Dilip Giri, Hannah Y Wen, Hong Zhang, Edi Brogi, Britta Weigelt, Fresia Pareja, Jorge S Reis-Filho
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations. NPJ precision oncology 8 (1) (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology 21 (3) (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology 21 (3) (2024)
Elisabetta Munzone, Antonio Marra, Federico Comotto, Lorenzo Guercio, Claudia Anna Sangalli, Martina Lo Cascio, Eleonora Pagan, Davide Sangalli, Ilaria Bigoni, Francesca Maria Porta, Marianna D'Ercole, Fabiana Ritorti, Vincenzo Bagnardi, Nicola Fusco, Curigliano Giuseppe
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports. JCO clinical cancer informatics 8 (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology (2024)
Higinio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, David N Brown, Pier Selenica, Sahar Jalali, Arnaud Da Cruz Paula, Antonio Marra, Edaise M Da Silva, Thais Basili, Laxmi Gusain, Lorraine Colon-Cartagena, Shirin Issa Bhaloo, Hunter Green, Chad Vanderbilt, Steffi Oesterreich, Anne Grabenstetter, M Gabriela Kuba, Dara Ross, Dilip Giri, Hannah Y Wen, Hong Zhang, Edi Brogi, Britta Weigelt, Fresia Pareja, Jorge S Reis-Filho
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations. NPJ precision oncology 8 (1) (2024)
Higinio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, David N Brown, Pier Selenica, Sahar Jalali, Arnaud Da Cruz Paula, Antonio Marra, Edaise M Da Silva, Thais Basili, Laxmi Gusain, Lorraine Colon-Cartagena, Shirin Issa Bhaloo, Hunter Green, Chad Vanderbilt, Steffi Oesterreich, Anne Grabenstetter, M Gabriela Kuba, Dara Ross, Dilip Giri, Hannah Y Wen, Hong Zhang, Edi Brogi, Britta Weigelt, Fresia Pareja, Jorge S Reis-Filho
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations. NPJ precision oncology 8 (1) (2024)
Fresia Pareja, Higinio Dopeso, Yi Kan Wang, Andrea M Gazzo, David N Brown, Monami Banerjee, Pier Selenica, Jan H Bernhard, Fatemeh Derakhshan, Edaise M Da Silva, Lorraine Colon Cartagena, Thais Basili de Oliveira, Antonio Marra, Jillian Sue, Qiqi Ye, Arnaud Da Cruz Paula, Selma Yeni Yildirim, Isaac X Pei, Anton Safonov, Hunter Green, Kaitlyn Y Gill, Yingjie Zhu, Matthew C H Lee, Ran A Godrich, Adam Casson, Jorge S Reis-Filho, Nadeem Riaz, Hannah Y Wen, Edi Brogi, Diana L Mandelker, Matthew G Hanna, Jeremy D Kunz, Brandon Rothrock, Sarat Chandarlapaty, Christopher Kanan, Joe Oakley, David S Klimstra, Thomas J Fuchs, Jorge Sergio Reis-Filho
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms. Cancer research (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology 21 (3) (2024)
Higinio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, David N Brown, Pier Selenica, Sahar Jalali, Arnaud Da Cruz Paula, Antonio Marra, Edaise M Da Silva, Thais Basili, Laxmi Gusain, Lorraine Colon-Cartagena, Shirin Issa Bhaloo, Hunter Green, Chad Vanderbilt, Steffi Oesterreich, Anne Grabenstetter, M Gabriela Kuba, Dara Ross, Dilip Giri, Hannah Y Wen, Hong Zhang, Edi Brogi, Britta Weigelt, Fresia Pareja, Jorge S Reis-Filho
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations. NPJ precision oncology 8 (1) (2024)
Jing Yu, Edaise M Da Silva, Hae-Sun La, Beth Z Clark, Jeffrey L Fine, Gloria J Carter, Tatiana M Villatoro, T Rinda Soong, Adrian V Lee, Steffi Oesterreich, Thais Basili de Oliveira, Juan Blanco-Heredia, Pier Selenica, Qiqi Ye, Arnaud Da Cruz Paula, Higinio Dopeso, Andrea Gazzo, Antonio Marra, Fresia Pareja, Jorge Sergio Reis-Filho, Rohit Bhargava
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity? NPJ breast cancer 9 (1) (2023)
Diana L Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica, Zarina Yelskaya, Ciyu Yang, Joshua Somar, Miika Mehine, Maksym Misyura, Olca Basturk, Alicia Latham, Maria Carlo, Michael Walsh, Zsofia K Stadler, Kenneth Offit, Chaitanya Bandlamudi, Meera Hameed, Ping Chi, Jorge Sergio Reis-Filho, Ozge Ceyhan-Birsoy
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. NPJ precision oncology 7 (1) (2023)
Diana L Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica, Zarina Yelskaya, Ciyu Yang, Joshua Somar, Miika Mehine, Maksym Misyura, Olca Basturk, Alicia Latham, Maria Carlo, Michael Walsh, Zsofia K Stadler, Kenneth Offit, Chaitanya Bandlamudi, Meera Hameed, Ping Chi, Jorge Sergio Reis-Filho, Ozge Ceyhan-Birsoy
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. NPJ precision oncology 7 (1) (2023)
Diana L Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica, Zarina Yelskaya, Ciyu Yang, Joshua Somar, Miika Mehine, Maksym Misyura, Olca Basturk, Alicia Latham, Maria Carlo, Michael Walsh, Zsofia K Stadler, Kenneth Offit, Chaitanya Bandlamudi, Meera Hameed, Ping Chi, Jorge Sergio Reis-Filho, Ozge Ceyhan-Birsoy
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. NPJ precision oncology 7 (1) (2023)
Diana L Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica, Zarina Yelskaya, Ciyu Yang, Joshua Somar, Miika Mehine, Maksym Misyura, Olca Basturk, Alicia Latham, Maria Carlo, Michael Walsh, Zsofia K Stadler, Kenneth Offit, Chaitanya Bandlamudi, Meera Hameed, Ping Chi, Jorge Sergio Reis-Filho, Ozge Ceyhan-Birsoy
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. NPJ precision oncology 7 (1) (2023)
Jorge S Reis-Filho, Antonio Marra, Pier Selenica, Eric V Rios-Doria, Amir Momeni Boroujeni, Michael F Berger, Kanika S Arora, David Nemirovsky, Alexia E Iasonos, Debyani Chakravarty, Nadeem R Abu-Rustum, Arnaud Da Cruz Paula, Kimberly Dessources, Lora H Ellenson, Ying L Liu, Carol Aghajanian, Carol L Brown
Molecular characterization of endometrial carcinomas in Black and White patients reveals disparate drivers with therapeutic implications. Cancer discovery (2023)
Emma Zattarin, Daniele Presti, Luigi Mariani, Caterina Sposetti, Rita Leporati, Alice Menichetti, Chiara Corti, Chiara Benvenuti, Giovanni Fucà, Riccardo Lobefaro, Francesca Ligorio, Leonardo Provenzano, Andrea Vingiani, Marta Del Vecchio, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi di Mauro, Andrea Esposito, Carlo Alberto Giorgi, Luca Lalli, Laura Boldrini, Pier Paolo Berton Giacchetti, Ambra Carnevale Schianca, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Alberto Zambelli, Daniele Generali, Carmen Criscitiello, Curigliano Giuseppe, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors. NPJ breast cancer 9 (1) (2023)
Diana L Mandelker, Antonio Marra, Binbin Zheng-Lin, Pier Selenica, Juan Blanco-Heredia, Yingjie Zhu, Andrea Gazzo, Donna Wong, Zarina Yelskaya, Vikas Rai, Joshua Somar, Silvana Ostafi, Nikita Mehta, Ciyu Yang, Yirong Li, David N Brown, Edaise M Da Silva, Xin Pei, Irina Linkov, Panieh Terraf, Maksym Misyura, Ozge Ceyhan-Birsoy, Marc Ladanyi, Michael F Berger, Fresia Pareja, Zsofia K Stadler, Kenneth Offit, Nadeem Riaz, Wungki Park, Joanne Chou, Marinela Capanu, Maria Koehler, Ezra Y Rosen, Eileen M O'Reilly, Jorge Sergio Reis-Filho
Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficien cy in Pancreatic Acinar Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Tony El Jabbour, Maksym Misyura, Darren Cowzer, Michal Zimmermann, Victoria Rimkunas, Antonio Marra, Fatemeh Derakhshan, Pier Selenica, Megan Parilla, Jeremy S Setton, Ozge Ceyhan-Birsoy, Yelena M Kemel, Amanda Catchings, Megha Ranganathan, Geoffrey Y Ku, Yelena Y Janjigian, Michael Zinda, Maria Koehler, Zsofia Stadler, Jinru Shia, Jorge Sergio Reis-Filho, Diana L Mandelker
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications. Journal of the National Cancer Institute 114 (5) (2022)
Fresia Pareja, Ryan N Ptashkin, David N Brown, Fatemeh Derakhshan, Pier Selenica, Edaise M Da Silva, Andrea M Gazzo, Arnaud Da Cruz Paula, Kelsey E Breen, Ronglai Shen, Antonio Marra, Ahmet Zehir, Ryma Benayed, Michael F Berger, Ozge Ceyhan-Birsoy, Sowmya Jairam, Margaret Sheehan, Utsav Patel, Yelena M Kemel, Jacklyn Casanova-Murphy, Christopher J Schwartz, Mahsa Vahdatinia, Elizabeth Comen, Laetitia Borsu, Isaac X Pei, Nadeem Riaz, David H Abramson, Britta Weigelt, Michael F Walsh, Anna-Katerina Hadjantonakis, Marc Ladanyi, Kenneth Offit, Zsofia K Stadler, Mark E Robson, Jorge S Reis-Filho, Diana Mandelker
Cancer-Causative Mutations Occurring in Early Embryogenesis. Cancer discovery 12 (4) (2022)
Charles W Ashley, Pier Selenica, Juber Patel, Michelle Wu, Josip Nincevic, Yulia Lakhman, Qin C Zhou, Ronak H Shah, Michael F Berger, Arnaud Da Cruz Paula, David N Brown, Antonio Marra, Alexia E Iasonos, Amir Momeni Boroujeni, Kaled M Alektiar, Kara Long Roche, Oliver Zivanovic, Jennifer J Mueller, Dmitriy Zamarin, Vance A Broach, Yukio Sonoda, Mario L Leitao, Claire F Friedman, Elizabeth L Jewell, Jorge Sergio Reis-Filho, Lora H Ellenson, Carol Aghajanian, Nadeem R Abu-Rustum, Karen A Cadoo, Jorge S Reis-Filho
High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Claudio Vernieri, Federico Nichetti, Luca Lalli, Luca Moscetti, Carlo Alberto Giorgi, Gaia Griguolo, Antonio Marra, Giovanni Randon, Carmen G Rea, Francesca Ligorio, Simone Scagnoli, Claudia De Angelis, Chiara Molinelli, Agnese Fabbri, Emanuela Ferraro, Dario Trapani, Andrea Milani, Elisa Agostinetto, Ottavia Bernocchi, Giovanna Catania, Amelia Vantaggiato, Michela Palleschi, Anna Moretti, Debora Basile, Marika Cinausero, Arta Ajazi, Lorenzo Castagnoli, Salvatore Lo Vullo, Lorenzo Gerratana, Fabio Puglisi, Nicla La Verde, Grazia Arpino, Andrea Rocca, Mariangela Ciccarese, Rebecca Pedersini, Alessandra Fabi, Daniele Generali, Agnese Losurdo, Filippo Montemurro, Curigliano Giuseppe, Lucia Del Mastro, Andrea Michelotti, Enrico Cortesi, Valentina Guarneri, Giancarlo Pruneri, Luigi Mariani, Filippo de Braud
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Christopher J Schwartz, Edaise M Da Silva, Antonio Marra, Andrea M Gazzo, Pier Selenica, Vikas K Rai, Diana Mandelker, Fresia Pareja, Maksym Misyura, Timothy M D'Alfonso, Edi Brogi, Pamela Drullinsky, Pedram Razavi, Mark E Robson, Joshua Z Drago, Hannah Y Wen, Zarina Yelskaya, Britta Weigelt, Jinru Shia, Jorge S Reis-Filho, Hong Zhang
Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Dara S Ross, Kelly A Devereaux, Cao Jin, David YunTe Lin, Yanming Zhang, Antonio Marra, Vicky Makker, Jorge S Reis-Filho, Lora H Ellenson, Michael Herman Chui
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (7) (2021)
Antonio Marra, Dario Trapani, Giulia Viale, Carmen Criscitiello, Curigliano Giuseppe
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies. NPJ breast cancer 6 (2020)
Fabio Conforti, Laura Pala, Vincenzo Bagnardi, Claudia Specchia, Chiara Oriecuia, Antonio Marra, Paola Zagami, Stefania Morganti, Paolo Tarantino, Chiara Catania, Filippo De Marinis, Paola Queirolo, Tommaso Martino De Pas
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials. JNCI cancer spectrum 4 (6) (2020)
Antonio Marra, Curigliano Giuseppe
Are all cyclin-dependent kinases 4/6 inhibitors created equal? NPJ breast cancer 5 (2019)
Federico Nichetti, Francesca Ligorio, Emma Zattarin, Diego Signorelli, Arsela Prelaj, Claudia Proto, Giulia Galli, Antonio Marra, Giulia Apollonio, Luca Porcu, Filippo de Braud, Giuseppe Lo Russo, Roberto Ferrara, Marina Chiara Garassino
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients. Cancers 12 (1) (2019)

Antonio Marra.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antonio Marra